Crown Bioscience
About Crown Bioscience
Crown Bioscience is a company based in Santa Clara (United States) founded in 2006 was acquired by Aidikang Medical Laboratory Center in November 2025.. Crown Bioscience has raised $85.87 million across 4 funding rounds from investors including Orbimed, JSR Corporation and European Union. The company has 18 employees as of December 31, 2022. Crown Bioscience has completed 3 acquisitions, including OcellO, PRECOS and PreClinOmics. Crown Bioscience offers products and services including PDX Models, CDX Models, Syngeneic Models, Organoids, and Bioinformatics Services. Crown Bioscience operates in a competitive market with competitors including Evotec, Alloy Therapeutics, Domainex, NIH and Viva Biotech, among others.
- Headquarter Santa Clara, United States
- Employees 18 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Crown Bioscience, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Crown Bioscience
Crown Bioscience offers a comprehensive portfolio of products and services, including PDX Models, CDX Models, Syngeneic Models, Organoids, and Bioinformatics Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Preclinical models for testing oncology drugs in humanized mice.
Cell-derived xenograft models for cancer research applications.
Models for immuno-oncology studies using immune-competent mice.
3D cell cultures for evaluating drug responses in oncology.
Tools for genomics and proteomics data in drug development.
Funding Insights of Crown Bioscience
Crown Bioscience has successfully raised a total of $85.87M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $159.68 thousand completed in September 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Grant — $159,679
-
First Round
First Round
(04 May 2011)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2017 | Amount | Grant - Crown Bioscience | Valuation |
investors |
|
| May, 2014 | Amount | Series C - Crown Bioscience | Valuation |
investors |
|
| Jul, 2013 | Amount | Series C - Crown Bioscience | Valuation | Orbimed , Qiming Venture Partners |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Crown Bioscience
Crown Bioscience has secured backing from 10 investors, including institutional and venture fund investors. Prominent investors backing the company include Orbimed, JSR Corporation and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location | |
|
Venture capital investments are directed toward multiple sectors.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Crown Bioscience
Crown Bioscience has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include OcellO, PRECOS and PreClinOmics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
3D screening services for drug discovery are offered.
|
2011 | ||||
|
Preclinical oncology services with xenograft and metastatic models are provided.
|
2010 | ||||
|
Contract research organization (CRO) with expertise in Metabolic, Renal and Cardiovascular disease
|
2001 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Crown Bioscience
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Crown Bioscience Comparisons
Competitors of Crown Bioscience
Crown Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evotec, Alloy Therapeutics, Domainex, NIH and Viva Biotech, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Drug discovery and development services are provided to biopharma sector.
|
|
| domain | founded_year | HQ Location |
Drug discovery services are provided for therapeutic development.
|
|
| domain | founded_year | HQ Location |
Drug discovery CRO company for epigenetic research and inflammatory diseases
|
|
| domain | founded_year | HQ Location |
Drug discovery services are provided to the biopharma sector.
|
|
| domain | founded_year | HQ Location |
Drug discovery and development research services are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Crown Bioscience
Frequently Asked Questions about Crown Bioscience
When was Crown Bioscience founded?
Crown Bioscience was founded in 2006 and raised its 1st funding round 5 years after it was founded.
Where is Crown Bioscience located?
Crown Bioscience is headquartered in Santa Clara, United States. It is registered at Santa Clara, California, United States.
Who is the current CEO of Crown Bioscience?
Armin Spura is the current CEO of Crown Bioscience.
Is Crown Bioscience a funded company?
Crown Bioscience is a funded company, having raised a total of $85.87M across 4 funding rounds to date. The company's 1st funding round was a Series C of $30.47M, raised on May 04, 2011.
How many employees does Crown Bioscience have?
As of Dec 31, 2022, the latest employee count at Crown Bioscience is 18.
What does Crown Bioscience do?
Crown Bioscience develops drugs for cancer and CVMD (Cardiovascular and Metabolic Diseases). The companys proprietary platform includes HuPrime that is a patient-derived xenograft (PDX) models which can be used for efficacy testing. It also offers oncology services, such as oncology databases, ex vivo services, human surrogate trials, in vitro and in vivo services, preclinical models (PDX, Humanized and Murine efficacyPD) for CAR-T Therapy Evaluation (immuno-oncology) etc., CrownBio also has a variety of rodent and mouse models for the development of drugs for CVMD. The company also offers products, such as antibodies for in vivo and in-vitro studies, tissues for CVMD research, tumor samples for Oncology RD, cytokines and growth factors for use in basic and preclinical research, recombinant proteins and cell lines for biological studies, immune checkpoint antibodies and tumor tissue microarrays. CrownBio has strategic partnerships with Xstrahl, a designer, and manufacturer of X-Ray solutions for radiation biology research and Horizon Discovery, a provider of advanced research tools and services for the development of personalized medicines. CrownBio acquired PreClinOmics, an in vivo preclinical company specializing in CVMD and renal disease research. The company has spun-off CBT pharmacueticals, an emerging life science oncology company.
Who are the top competitors of Crown Bioscience?
What products or services does Crown Bioscience offer?
Crown Bioscience offers PDX Models, CDX Models, Syngeneic Models, Organoids, and Bioinformatics Services.
How many acquisitions has Crown Bioscience made?
Crown Bioscience has made 3 acquisitions, including OcellO, PRECOS, and PreClinOmics.
Who are Crown Bioscience's investors?
Crown Bioscience has 10 investors. Key investors include Orbimed, JSR Corporation, European Union, Qiming Venture Partners, and CDIB Capital Group.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.